Elon Musk's 'Neuralink' Set To Start Clinical Trials For Human Brain Chip Implants
Billionaire tech businessman Elon Musk is looking to make new strides with neurotechnology company Neuralink Corp., which wants to put a computer chip into the human brain to control devices.
The blueprints for Neuralink first became public in April 2017, but the company's recent job listing for “Clinical Trial Director” is perhaps the first real sign of progress towards a device being tested on humans.
“As the Clinical Trial Director, you’ll work closely with some of the most innovative doctors and top engineers, as well as working with Neuralink’s first Clinical Trial participants," according to the job description.
“You will lead and help build the team responsible for enabling Neuralink’s clinical research activities and developing the regulatory interactions that come with a fast-paced and ever-evolving environment. You are mission-driven and are able to meet tight deadlines with accuracy and efficiency,” the description added.
Neuralink technology involves a “brain-machine interface” or “BMI system” that allows a computer or other digital device to communicate directly with the brain, according to Neuralink’s website. The Neuralink chip is placed inside the brain and allows for wireless communication through the skin. This gives the ability to control a computer or mobile device with just thoughts.
One of Neuralink's goals is to help those who suffer from insomnia, memory loss, hearing loss, and depression.
The chip has yet to be tested on humans. In April 2021, the company released a video showing a monkey playing “MindPong” with an implanted Neuralink.
Musk, who is listed as the world's richest person, founded Neuralink in July 2016. The company is headquartered in San Francisco.
© Copyright IBTimes 2024. All rights reserved.